In Patients with Ankylosing Spondylitis Treated with Adalimumab, Combination Therapy with DMARD, Increase the Serum Level of Adalimumab and Decrease Immunogenicity Conference Poster 2016 Congress communication uri icon

authors

  • BARBER VALLES, JOSEP XAVIER
  • Gregorio Santos-Soler Esteban Salas-Heredia Catalina Cano Juan Molina Marina Sanchís
  • José Rosas Francisca Llinares-Tello José Miguel Senabre-Gallego Mariana Marco-Mingot Ana Pon
  • Mario García-Carrasco and AIRE-MB Group

publication date

  • 2016